Increased serum transferrin saturation is associated with lower serum transferrin receptor concentration

Clinical Chemistry

Volumn 45, Issue 12, 1999, Pages 2191-2199

  Looker, Anne C ^a   Loyevsky, Mark ^b   Gordeuk, Victor R ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ERYTHROCYTE PROTOPORPHYRIN; FERRITIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEALTH SURVEY; HEMOCHROMATOSIS; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON OVERLOAD; LOADING TEST; MAJOR CLINICAL STUDY; MALE; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; TRANSFERRIN BLOOD LEVEL;

EID: 0032708745     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.12.2191     Document Type: Article

References (52)

1. 1. Beguin Y, Clemons G, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of transferrin receptor and erythropoietin. Blood 1993;81:1067-76.
2. 2. Baynes RD. Refining the assessment of body iron stores. Am J Clin Nutr 1996;64:793-4.
3. 3. Cook JD, Skikne B, Baynes R. The use of serum transferrin receptor for the assessment of iron status. In: Hallberg L, Asp N-G, eds. Iron nutrition in health and disease. London: John Libbey & Co, 1996:49-58.
4. 4. Kohgo Y, Niitsu Y, Nishisato T, Kalo J, Kondo H, Sasaki K, Urushizaki I. Quantitation and characterisation of serum transferrin receptor in patients with anemias and polycythemias. Jpn J Med 1988;27:64-70.
5. 5. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptors: quantitative measure of tissue iron deficiency. Blood 1990;75: 1870-6.
6. 6. Flowers CH, Skikne BS, Covell AM, Cook JD. Clinical measurement of serum transferrin receptors. J Lab Clin Med 1989;114:368-77.
7. 7. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102-7.
8. 8. Baynes RD, Cook JD. Bothwell T, Friedman BM, Meyer TE. Serum transferrin receptors in hereditary hemochromatosis and African siderosis. Am J Hematol 1994;45:288-92.
9. 9. Thorstensen K, Romslo I. Measurement of serum transferrin receptors in screening for hemochromatosis [Letter]. Clin Chem 1992;38:1510.
10. 10. Ledue TB, Craig WY. Serum concentrations of transferrin receptor in hereditary hemochromatosis [Letter]. Clin Chem 1995;41: 1053-4.
11. 11. Khumalo H, Gomo ZAR, Moyo VM, Gordeuk VR, Saungweme T, Roualt T, Gangaidzo IT. Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem 1998;44:40-4.
12. 12. Centis F, Delfini C, Agostinelli F, Barbanti I, Annibali M, Lucarelli G. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia. Eur J Haematol 1995;54:329-33.
13. 13. National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1(32). DHHS Publication No. PHS 94-1308. Hyattsville, MD: NCHS, 1994.
14. 14. Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev 1995;53:246-54.
15. 15. CDC. Iron overload disorders among Hispanics-San Diego California, 1995. Morbid Mortal Wkly Rep 1996;45:991-3.
16. 16. Custer EM, Finch CA, Sobel RE, Zettner A. Population norms for serum ferritin. J Lab Clin Med 1995;126:88-94.
17. 17. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.
18. 18. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997; 227:973-6.
19. 19. Expert Scientific Working Group. Summary of a report on assessment of the iron nutritional status of the United States. Am J Clin Nutr 1985;42:1318-30.
20. 20. Gunter EW, Lewis BL, Koncikowski SM. Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 [CD-ROM; Available from National Technical Information Service (NTIS), Springfield, VA]. Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
21. 21. SAS Institute, Inc. SAS user's guide, Ver. 6, 4th ed. Cary, NC: SAS Institute, 1989:943pp.
22. 22. Rothman KJ. Modern epidemiology. Boston, MA: Little, Brown & Co., 1986:236-83.
23. 23. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989:123-9.
24. 24. Turkewitz AP, Amatruda JF, Borhani D, Harrison SC, Schwatz AL. A high yield purification of the human transferrin receptor and properties of its major extracellular fragment. J Biol Chem 1988; 263:8318-25.
25. 25. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993;72:19-28.
26. 26. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 1996;93: 8175-82.
27. 27. Halle DJ, Rouault TA, Tang CK, Chin J, Harford JB, Klausner RD. Reciprocal control of RNA binding and aconitase activity in the regulation of iron responsive element binding protein: role of iron sulfur cluster. Proc Natl Acad Sci U S A 1992;89:7536-40.
28. 28. Rouault T, Rao K, Harford J, Mattia E, Klausner RD. Hemin, chelatable iron, and the regulation of transferrin receptor biosynthesis. J Biol Chem 1985;260:14862-6.
29. 29. Rouault TA, Hentze MW, Caughman SW, Harford BJ, Klausner RD. Binding of a cytosolic protein to the iron responsive element of human ferritin messenger RNA. Science 1988;241:1207-10.
30. 30. Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford HB, Klausner RD. Identification of the iron responsive element for the transcriptional regulation of human ferritin mRNA. Science 1987;238:1570-3.
31. 31. Casey JL, Koeller DM, Ramin VC, Klausner RD, Harford JB. Iron regulation of transferrin receptor mRNA requires iron responsive elements and a rapid turnover of determinants in the 3′ untranslated region of the mRNA. EMBO J 1989;8:3693-9.
32. 32. Haile DJ, Rouault TA, Harford JB, Kennedy MC, Blondin GA, Beinert H, Klausner RO. Cellular regulation of the iron responsive element binding protein: disassembly of the cubane iron-sulfur cluster results in high affinity RNA binding. Proc Natl Acad Sci U S A 1992;89:11735-9.
33. 33. Bridges KR, Cudkowicz A. Effect of iron chelators on transferrin receptors in K562 cells. J Biol Chem 1984;259:12970-7.
34. 34. Baynes RD, Shih YJ, Cook JD. Production of soluble transferrin receptor in K562 erythroleukaemia cells. Br J Haematol 1991;78: 450-5.
35. 35. Lombard M, Bomford A, Hynes M, Naoumov NV, Roberts S, Crowe J, Williams R. Regulation of hepatic transferrin receptor in hemochromatosis. Hepatology 1989;9:1-5.
36. 36. De Vos R, Sciot R, Van Eyken P, Desmet VJ. Immunoelectron microscopic localization of hepatic transferrin receptors in human liver with and without iron overload. Virchows Arch B Cell Pathol Incl Mol Pathol 1988;55:11-7.
37. 37. Ward JH, Kushner JP, Ray FA, Kaplan J. Transferrin receptor function in hereditary hemachromatosis. J Lab Clin Med 1984; 103:246-54.
38. 38. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
39. 39. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
40. 40. Gordeuk VR, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.
41. 41. McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T. Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene? Br J Haematol 1998;102:1176-8.
42. 42. Terasaki Pl, ed. Histocompatibility testing. Los Angeles: UCLA Tissue Typing Laboratory, 1980;955.
43. 43. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
44. 44. Hanis CL, Hewett-Emmett D, Bertin TK, Schull WJ. Origins of U.S. Hispanics. Implications for diabetes. Diabetes Care 1991; 14(Suppl 3);618-27.
45. 45. Long JC, Williams RC, McAuley JE, Medis R, Partel R, Tregellas WM, et al. Genetic variation in Arizona Mexican Americans: estimation and interpretation of admixture proportions. Am J Phys Anthropol 1991;84:141-57.
46. 46. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998;29:725-8.
47. 47. Baiget M, Barcelo MJ, Gimferrer E. Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain [Letter]. J Med Genet 1998;35:701.
48. 48. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood 1976;48:449-55.
49. 49. Olsson KS, Eriksson K, Ritter B, Heedman PA. Screening for iron overload using transferrin saturation. Acta Med Scand 1984;215: 105-12.
50. 50. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev 1996;54:73-84.
51. 51. Stevens RG. Iron and the risk of cancer. Med Oncol Tumor Pharmacother 1990;7:177-81.
52. 52. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997;20:426-8.